go 6976 has been researched along with Multiple Myeloma in 1 studies
Multiple Myeloma: A malignancy of mature PLASMA CELLS engaging in monoclonal immunoglobulin production. It is characterized by hyperglobulinemia, excess Bence-Jones proteins (free monoclonal IMMUNOGLOBULIN LIGHT CHAINS) in the urine, skeletal destruction, bone pain, and fractures. Other features include ANEMIA; HYPERCALCEMIA; and RENAL INSUFFICIENCY.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Despite high dose treatment regimes multiple myeloma (MM) disease is still not curable." | 1.35 | Inhibitors of protein kinase C sensitise multiple myeloma cells to common genotoxic drugs. ( Armann, J; Baumann, P; Grün, G; Mandl-Weber, S; Oduncu, F; Schmidmaier, R, 2008) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Baumann, P | 1 |
| Armann, J | 1 |
| Mandl-Weber, S | 1 |
| Grün, G | 1 |
| Oduncu, F | 1 |
| Schmidmaier, R | 1 |
1 other study available for go 6976 and Multiple Myeloma
| Article | Year |
|---|---|
Inhibitors of protein kinase C sensitise multiple myeloma cells to common genotoxic drugs.
Topics: Antineoplastic Agents; Apoptosis; Bone Marrow; Carbazoles; Cell Proliferation; Cells, Cultured; Doxo | 2008 |